Reuters logo
BRIEF-Medivir completes oncology acquisition
December 29, 2016 / 3:40 PM / a year ago

BRIEF-Medivir completes oncology acquisition

Dec 29 (Reuters) - Medivir Ab

* Medivir completes previously announced oncology programs acquisition

* Says acquisitions of the two clinical stage oncology programs from TetraLogic Pharmaceuticals Corporation have been completed

* In connection with the closing, Medivir has paid the upfront payment of US$12M to TetraLogic Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below